China’s tightening grip over critical mineral supply chains has long posed strategic risks to the United States. But Beijing’s expanding control over pharmaceutical ingredients may prove even more dangerous. In recent years, Chinese exporters have quietly pumped unregulated and frequently counterfeit active pharmaceutical ingredients (APIs) into America, exploiting gaps in US law and Washington’s sluggish implementation of drug-tracking requirements. These schemes—often involving mislabeled packages and gray-market distributors—have already resulted in hospitalizations and deaths, revealing how China’s leverage over essential medical inputs directly threatens Americans’ health and safety. As with minerals and manufacturing, the Chinese Communist Party is increasingly using its control over APIs to undermine US interests. Policymakers should move quickly to strengthen oversight, close loopholes in the pharmaceutical supply chain, and shift critical API production back to trusted domestic sources.
To discuss how America can restore its sovereignty in pharmaceuticals, Michael Sobolik will host former US Representative Ted Yoho and an expert panel.
Listen on Apple Podcasts and Spotify.
Please join Hudson Institute for a fireside chat with Senior Fellow and Keystone Defense Initiative Director Rebeccah Heinrichs and John Spencer, chair of Urban Warfare Studies at the Modern War Institute at West Point and co-director of the Urban Warfare Project.
Join Hudson Institute and the Ben Franklin Fellowship for a two-panel discussion examining US policy as it confronts the crisis of terror in Nigeria.
Join Hudson Institute's Center for the Economics of the Internet for a keynote address given by Tricia Paoletta on the Trump administration's progress in managing and reallocating the electromagnetic radio frequency spectrum from the federal domain.
Join Hudson Institute for a discussion with Federal Trade Commission Chairman Andrew Ferguson and Senior Fellow Harold Furchtgott-Roth.
